Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Chacko, Liza"'
Autor:
Howard JP; National Heart and Lung Institute, Imperial College London, Du Cane Rd, B Block, 2nd Floor, Hammersmith Hospital, London W12 0HS, England (J.P.H., G.D.C.); National Amyloidosis Centre, Division of Medicine, University College London, London, England (L.C., M.F.); Cardiovascular MR R&D, Siemens Medical Solutions USA, Chicago, Ill (K.C., L.C., M.F.); and Medical Signal and Image Processing Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (P.K., H.X.)., Chow K; National Heart and Lung Institute, Imperial College London, Du Cane Rd, B Block, 2nd Floor, Hammersmith Hospital, London W12 0HS, England (J.P.H., G.D.C.); National Amyloidosis Centre, Division of Medicine, University College London, London, England (L.C., M.F.); Cardiovascular MR R&D, Siemens Medical Solutions USA, Chicago, Ill (K.C., L.C., M.F.); and Medical Signal and Image Processing Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (P.K., H.X.)., Chacko L; National Heart and Lung Institute, Imperial College London, Du Cane Rd, B Block, 2nd Floor, Hammersmith Hospital, London W12 0HS, England (J.P.H., G.D.C.); National Amyloidosis Centre, Division of Medicine, University College London, London, England (L.C., M.F.); Cardiovascular MR R&D, Siemens Medical Solutions USA, Chicago, Ill (K.C., L.C., M.F.); and Medical Signal and Image Processing Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (P.K., H.X.)., Fontana M; National Heart and Lung Institute, Imperial College London, Du Cane Rd, B Block, 2nd Floor, Hammersmith Hospital, London W12 0HS, England (J.P.H., G.D.C.); National Amyloidosis Centre, Division of Medicine, University College London, London, England (L.C., M.F.); Cardiovascular MR R&D, Siemens Medical Solutions USA, Chicago, Ill (K.C., L.C., M.F.); and Medical Signal and Image Processing Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (P.K., H.X.)., Cole GD; National Heart and Lung Institute, Imperial College London, Du Cane Rd, B Block, 2nd Floor, Hammersmith Hospital, London W12 0HS, England (J.P.H., G.D.C.); National Amyloidosis Centre, Division of Medicine, University College London, London, England (L.C., M.F.); Cardiovascular MR R&D, Siemens Medical Solutions USA, Chicago, Ill (K.C., L.C., M.F.); and Medical Signal and Image Processing Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (P.K., H.X.)., Kellman P; National Heart and Lung Institute, Imperial College London, Du Cane Rd, B Block, 2nd Floor, Hammersmith Hospital, London W12 0HS, England (J.P.H., G.D.C.); National Amyloidosis Centre, Division of Medicine, University College London, London, England (L.C., M.F.); Cardiovascular MR R&D, Siemens Medical Solutions USA, Chicago, Ill (K.C., L.C., M.F.); and Medical Signal and Image Processing Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (P.K., H.X.)., Xue H; National Heart and Lung Institute, Imperial College London, Du Cane Rd, B Block, 2nd Floor, Hammersmith Hospital, London W12 0HS, England (J.P.H., G.D.C.); National Amyloidosis Centre, Division of Medicine, University College London, London, England (L.C., M.F.); Cardiovascular MR R&D, Siemens Medical Solutions USA, Chicago, Ill (K.C., L.C., M.F.); and Medical Signal and Image Processing Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (P.K., H.X.).
Publikováno v:
Radiology. Artificial intelligence [Radiol Artif Intell] 2022 Nov 09; Vol. 5 (1), pp. e220050. Date of Electronic Publication: 2022 Nov 09 (Print Publication: 2023).